The Cell and Gene Therapy Catapult (CGT Catapult)
CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies, with a vision for a thriving industry delivering life-changing advanced therapies to the world.
Latest Content
Product News
Spliceor Receives Investment From the Cell and Gene Therapy Catapult as Part of the Cross-Catapult Investment Pilot
Spliceor receives CGT Catapult funding to develop a trans-splicing gene therapy platform for liver cancer treatment.
Product News
Plurify and the Cell and Gene Therapy Catapult To Develop Technology That Improves Purity of Cell Therapies
The Cell and Gene Therapy Catapult (CGT Catapult), and Plurify have received over £340,000 funding from Innovate UK as part of the Transforming Medicines Manufacturing Programme.
Advertisement
